The role of EGFR-directed therapy in the treatment of breast cancer.
about
Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapyInhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cellsChallenges in the Treatment of Triple Negative and HER2-Overexpressing Breast CancerBif-1 suppresses breast cancer cell migration by promoting EGFR endocytic degradationEGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia.Tannic acid, a potent inhibitor of epidermal growth factor receptor tyrosine kinase.
P2860
The role of EGFR-directed therapy in the treatment of breast cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The role of EGFR-directed therapy in the treatment of breast cancer.
@ast
The role of EGFR-directed therapy in the treatment of breast cancer.
@en
The role of EGFR-directed therapy in the treatment of breast cancer.
@nl
type
label
The role of EGFR-directed therapy in the treatment of breast cancer.
@ast
The role of EGFR-directed therapy in the treatment of breast cancer.
@en
The role of EGFR-directed therapy in the treatment of breast cancer.
@nl
prefLabel
The role of EGFR-directed therapy in the treatment of breast cancer.
@ast
The role of EGFR-directed therapy in the treatment of breast cancer.
@en
The role of EGFR-directed therapy in the treatment of breast cancer.
@nl
P356
P1476
The role of EGFR-directed therapy in the treatment of breast cancer.
@en
P2093
Charles Morris
P2888
P304
S51-5; discussion S57-9
P356
10.1023/A:1020370018668
P407
P478
75 Suppl 1
P577
2002-10-01T00:00:00Z
P6179
1005924783